Merit Medical Systems, Inc. (MMSI)

NASDAQ: MMSI · IEX Real-Time Price · USD
72.90
+0.48 (0.66%)
Mar 30, 2023, 10:26 AM EDT - Market open
0.66%
Market Cap 4.18B
Revenue (ttm) 1.15B
Net Income (ttm) 74.52M
Shares Out 57.32M
EPS (ttm) 1.29
PE Ratio 56.14
Forward PE 25.32
Dividend n/a
Ex-Dividend Date n/a
Volume 10,723
Open 72.69
Previous Close 72.42
Day's Range 72.42 - 73.00
52-Week Range 50.46 - 76.14
Beta 0.99
Analysts Buy
Price Target 79.82 (+9.49%)
Earnings Date Apr 26, 2023

About MMSI

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid man... [Read more]

Sector Healthcare
IPO Date Aug 9, 1990
Employees 6,900
Stock Exchange NASDAQ
Ticker Symbol MMSI
Full Company Profile

Financial Performance

In 2022, MMSI's revenue was $1.15 billion, an increase of 7.09% compared to the previous year's $1.07 billion. Earnings were $74.52 million, an increase of 53.79%.

Financial Statements

Analyst Forecast

According to 14 analysts, the average rating for MMSI stock is "Buy." The 12-month stock price forecast is $79.82, which is an increase of 9.49% from the latest price.

Price Target
$79.82
(9.49% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Merit Medical's (MMSI) New Launch to Boost its Product Suite

Merit Medical's (MMSI) latest addition to its Vascular portfolio is expected to significantly enhance patient outcomes.

1 week ago - Zacks Investment Research

Merit Medical Launches Expanded SwiftNINJA® Steerable Microcatheter Offering

New sizes of advanced articulating microcatheter enhance a market-leading portfolio of vascular access products New sizes of advanced articulating microcatheter enhance a market-leading portfolio of v...

1 week ago - GlobeNewsWire

Here's Why You Should Retain Merit Medical (MMSI) Stock for Now

Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.

2 weeks ago - Zacks Investment Research

MMSI vs. WST: Which Stock Is the Better Value Option?

MMSI vs. WST: Which Stock Is the Better Value Option?

Other symbols: WST
1 month ago - Zacks Investment Research

Merit Medical (MMSI) Q4 Earnings Top Estimates, Margins Down

Merit Medical (MMSI), in the fourth quarter, benefits from revenue growth in its Cardiovascular segment and the majority of product categories within its Cardiovascular unit.

1 month ago - Zacks Investment Research

Merit Medical (MMSI) Q4 Earnings and Revenues Surpass Estimates

Merit Medical (MMSI) delivered earnings and revenue surprises of 17.91% and 1.26%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2022 Issues Fiscal Year 2023 Guidance

* Constant currency revenue; constant currency revenue, organic; non-GAAP EPS; non-GAAP net income; non-GAAP operating income and margin; non-GAAP gross profit and margin; and free cash flow are non-G...

1 month ago - GlobeNewsWire

Merit Medical Receives FDA Breakthrough Device Designation for the New SCOUT® MD™ Surgical Guidance System

Next-generation system helps improve surgical precision to enhance patient care in breast and other soft tissue cancer treatment Next-generation system helps improve surgical precision to enhance pati...

1 month ago - GlobeNewsWire

Merit Medical Systems to Announce Fourth Quarter and Year End 2022 Results and Issue Fiscal Year 2023 Guidance on February 22, 2023

SOUTH JORDAN, Utah, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will rele...

1 month ago - GlobeNewsWire

5 Dental Supplies Stocks to Buy Amid Recovering Prospects

Here, we discuss five stocks from the Dental Supplies industry that are likely to create wealth for investors - MCK, ABC, LH, CAH and MMSI.

Other symbols: ABCCAHLHMCK
1 month ago - Zacks Investment Research

MMSI or ALGN: Which Is the Better Value Stock Right Now?

MMSI vs. ALGN: Which Stock Is the Better Value Option?

Other symbols: ALGN
2 months ago - Zacks Investment Research

Reasons to Add Merit Medical (MMSI) Stock to Your Portfolio

Investors continue to be optimistic about Merit Medical (MMSI), owing to its strong product portfolio.

2 months ago - Zacks Investment Research

MMSI vs. ALGN: Which Stock Is the Better Value Option?

MMSI vs. ALGN: Which Stock Is the Better Value Option?

Other symbols: ALGN
2 months ago - Zacks Investment Research

Merit Medical (MMSI) Hits 52-Week High: What's Driving It?

Investors are optimistic about Merit Medical's (MMSI) slew of product launches.

4 months ago - Zacks Investment Research

First Patient Enrolled in Merit Medical's Multicenter Observational Study to Evaluate the Use of EmboCube® Embolization Gelatin to Control Bleeding or Hemorrhage

SOUTH JORDAN, Utah, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today the successful en...

4 months ago - GlobeNewsWire

Merit Medical (MMSI) Launches New Inflation Device basixALPHA

Merit Medical (MMSI) launches basixALPHA inflation device in the United States for one-handed preparation and fast inflation with minimal exertion to streamline angioplasty procedures.

4 months ago - Zacks Investment Research

Merit Medical Launches the basixALPHA™ Inflation Device

Ergonomic device provides fast inflation to streamline angioplasty procedures Ergonomic device provides fast inflation to streamline angioplasty procedures

4 months ago - GlobeNewsWire

Merit Medical's (MMSI) New Launch to Boost Patient Outcome

Merit Medical's (MMSI) latest addition to its radial portfolio is expected to significantly optimize hemostasis for radial artery procedures.

4 months ago - Zacks Investment Research

Fred Lampropoulos Receives Manufacturing Leader of the Year Award from the Utah Manufacturers Association

SOUTH JORDAN, Utah, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced that Fred Lampropoulos,...

4 months ago - GlobeNewsWire

Merit Medical Launches the PreludeSYNC EZ™ Radial Compression Device

Unique band provides precise placement and clear visibility of the access site, optimizing hemostasis for radial artery procedures Unique band provides precise placement and clear visibility of the ac...

4 months ago - GlobeNewsWire

MMSI vs. CNMD: Which Stock Should Value Investors Buy Now?

MMSI vs. CNMD: Which Stock Is the Better Value Option?

Other symbols: CNMD
4 months ago - Zacks Investment Research

Summary Notice to Current Merit Medical Systems, Inc. Stockholders of Derivative Action and Settlement Hearing

SALT LAKE CITY, Nov. 02, 2022 (GLOBE NEWSWIRE) -- TO: ALL OWNERS OF MERIT MEDICAL SYSTEMS, INC. (“MERIT” OR THE “COMPANY”) COMMON STOCK AS OF AUGUST 17, 2022 (“CURRENT MERIT STOCKHOLDERS”)

5 months ago - GlobeNewsWire

Merit Medical Announces the Appointment of Joe Wright to Chief Commercial Officer

Merit's long-time executive, Joe Wright, has been appointed to the new role of Chief Commercial Officer and will be responsible for leading all commercial activities for the global organization. Merit...

5 months ago - GlobeNewsWire

Merit Medical (MMSI) Q3 Earnings Beat, FY22 View Revised

Merit Medical (MMSI), in the third quarter, benefits from revenue growth in both its segments and the majority of product categories within its Cardiovascular unit.

5 months ago - Zacks Investment Research

Merit Medical (MMSI) Q3 Earnings and Revenues Top Estimates

Merit Medical (MMSI) delivered earnings and revenue surprises of 20.75% and 5.18%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research